Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
3 Stocks That Could Help You Retire a Millionaire
10:06am, Saturday, 09'th Apr 2022 The Motley Fool
These stocks have promising futures -- and could be big moneymakers for you.
As COVID-19 cases decline in the U.S., White House officials face outbreak
07:09pm, Friday, 08'th Apr 2022 MarketWatch
House Speaker Nancy Pelosi (D-Calif.) is the latest official to test positive for COVID-19 after attending an event with President Joe Biden.
Pfizer (PFE) to Boost RSV Portfolio With ReViral Acquisition
04:26pm, Friday, 08'th Apr 2022 Zacks Investment Research
Pfizer (PFE) inks an agreement to acquire ReViral for up to $525 million, which will add the latter's respiratory syncytial virus therapeutic candidates to its portfolio.
Why Novavax Stock Dropped 23.6% This Week
04:20pm, Friday, 08'th Apr 2022 The Motley Fool
The company is still waiting for the FDA to give Emergency Use Authorization for its COVID-19 vaccine.
3 Things About Pfizer That Smart Investors Know
03:07pm, Friday, 08'th Apr 2022 The Motley Fool
The next few years might get a little bumpy.
Centennial Resource Development and ShotSpotter have been highlighted as Zacks Bull and Bear of the Day
02:41pm, Friday, 08'th Apr 2022 Zacks Investment Research
Centennial Resource Development and ShotSpotter are part of Zacks Bull and Bear of the Day article.
Pharma Stock Roundup: PFE to Buy RSV Drugmaker, FDA Updates for NVS, MRK and RHHBY
01:28pm, Friday, 08'th Apr 2022 Zacks Investment Research
Pfizer (PFE) announces plans to acquire ReViral for up to $525 million. Merck (MRK), Novartis (NVS) and Roche (RHHBY) provide FDA updates.
Is Trending Stock Pfizer Inc. (PFE) a Buy Now?
01:09pm, Friday, 08'th Apr 2022 Zacks Investment Research
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Company News for Apr 8, 2022
12:58pm, Friday, 08'th Apr 2022 Zacks Investment Research
Companies In The News Are: STZ, LW, CAG, PFE
Here's Why a Drop in Moderna's Revenue Wouldn't Be Catastrophic
12:00pm, Friday, 08'th Apr 2022 The Motley Fool
Moderna is preparing the terrain for more sales down the road.
2 Hot Stocks to Buy and Hold Until You Retire
10:00am, Friday, 08'th Apr 2022 The Motley Fool
Their popularity may be long-lasting.
A $10 billion funding package for next phase of COVID battle stalls in Senate, as cases start climbing again in 28 states
06:37pm, Thursday, 07'th Apr 2022 MarketWatch
A $10 billion measure aimed at bolstering the governments COVID-19 defenses stalled in the Senate on Wednesday and is expected to remain in limbo for weeks.
Why Pfizer Stock Is Rising Today
03:43pm, Thursday, 07'th Apr 2022 The Motley Fool
Pfizer's planned acquisition of ReViral appears to be a smart move.
EU Agencies Doubtful About Need for 2nd COVID Booster
01:26pm, Thursday, 07'th Apr 2022 Zacks Investment Research
The European health agencies agreed that the fourth dose of mRNA-based COVID-19 vaccines of Pfizer (PFE)/BioNTech (BNTX) and Moderna (MRNA) may be given to adults 80 years and above.
Why Pfizer Stock Rose 10.3% in March
12:32pm, Thursday, 07'th Apr 2022 The Motley Fool
The company's COVID-19 vaccine appears to be likely to bring in revenue for a while.
